Vaneck Vectors Pharmaceutical etf shares owned by Beacon Pointe Advisors
Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Beacon Pointe Advisors
from 13F filings
Historical chart of Beacon Pointe Advisors investment in Vaneck Vectors Pharmaceutical etf
Tip: Access up to 7 years of quarterly data
All positions including Vaneck Vectors Pharmaceutical etf held by Beacon Pointe Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Beacon Pointe Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $373k | 3.6k | 103.88 |
| 2025-06-30 | $214k | 2.4k | 87.96 |
| 2025-03-31 | $221k | 2.4k | 91.13 |
| 2024-12-31 | $210k | 2.4k | 86.28 |
| 2024-09-30 | $231k | 2.4k | 95.03 |
| 2024-06-30 | $222k | 2.4k | 91.48 |
| 2024-03-31 | $220k | 2.4k | 90.70 |
| 2023-03-31 | $262k | 3.4k | 77.63 |
| 2022-12-31 | $237k | 3.1k | 77.74 |
| 2022-09-30 | $207k | 3.1k | 67.80 |
| 2022-06-30 | $235k | 3.1k | 76.97 |
| 2022-03-31 | $216k | 2.7k | 79.91 |
Top funds holding Vaneck Vectors Pharmaceutical etf
View all funds holding Vaneck Vectors Pharmaceutical etf